1-3 of 3
Sayaka Iwama
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tumor Suppressive Mir-7 Targeting PSME3 Improves the Efficacy of Histone Deacetylases Inhibitors in Multiple Myeloma

Masahiro Yamada, Sho Ikeda, Wataru Kuroki, Sayaka Iwama, Yuto Takahashi, Akihiro Kitadate, Fumito Abe, Hiroyuki Tagawa, Naoto Takahashi
Journal: Blood
Blood (2023) 142 (Supplement 1): 6592.
https://doi.org/10.1182/blood-2023-173475
Published: 2023
Journal Articles

Multiple Myeloma with 1q Gain/Amplification Shows Reduced CD38 Expression Via IL-6R Overexpression

Wataru Kuroki, Akihiro Kitadate, Masahiro Yamada, Sayaka Iwama, Yuto Takahashi, Yuki Fujioka, Takahiro Kobayashi, Sho Ikeda, Kentaro Narita, Kosei Matsue, Naoto Takahashi
Journal: Blood
Blood (2023) 142 (Supplement 1): 637.
https://doi.org/10.1182/blood-2023-173494
Published: 2023
Journal Articles

STAT3 Is a Potential Therapeutic Target for Histone Deacetylase Inhibitor-Resistant Cutaneous T-Cell Lymphoma

Yuto Takahashi, Akihiro Kitadate, Sho Ikeda, Sayaka Iwama, Ko Abe, Hiroyuki Tagawa, Hideki Wakui, Naoto Takahashi
Journal: Blood
Blood (2022) 140 (Supplement 1): 5971–5972.
https://doi.org/10.1182/blood-2022-165113
Published: 2022